SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Grosskreutz Julian) ;pers:(Corcia Philippe)"

Sökning: WFRF:(Grosskreutz Julian) > Corcia Philippe

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Al-Chalabi, Ammar, et al. (författare)
  • July 2017 ENCALS statement on edaravone
  • 2017
  • Ingår i: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. - : TAYLOR & FRANCIS LTD. - 2167-8421 .- 2167-9223. ; 18:7-8, s. 471-474
  • Tidskriftsartikel (refereegranskat)abstract
    • n/a
  •  
2.
  • Kliest, Tessa, et al. (författare)
  • Clinical trials in pediatric ALS: a TRICALS feasibility study
  • 2022
  • Ingår i: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. - : Taylor & Francis Group. - 2167-8421 .- 2167-9223. ; 23:7-8, s. 481-488
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA).Objective: To assess the feasibility of clinical studies on the effect of therapy in children (<18 years) with ALS in Europe.Methods: The EMA database was searched for submitted PIPs in ALS. A questionnaire was sent to 58 European ALS centers to collect the prevalence of pediatric ALS during the past ten years, the recruitment potential for future pediatric trials, and opinions of ALS experts concerning a waiver for ALS.Results: Four PIPs were identified; two were waived and two are planned for the future. In total, 49 (84.5%) centers responded to the questionnaire. The diagnosis of 44,858 patients with ALS was reported by 46 sites; 39 of the patients had an onset < 18 years (prevalence of 0.008 cases per 100,000 or 0.087% of all diagnosed patients). The estimated recruitment potential (47 sites) was 26 pediatric patients within five years. A majority of ALS experts (75.5%) recommend a waiver should apply for ALS due to the low prevalence of pediatric ALS.Conclusions: ALS with an onset before 18 years is extremely rare and may be a distinct entity from adult ALS. Conducting studies on the effect of disease-modifying therapy in pediatric ALS may involve lengthy recruitment periods, high costs, ethical/legal implications, challenges in trial design and limited information.
  •  
3.
  • van Rheenen, Wouter, et al. (författare)
  • Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
  • 2016
  • Ingår i: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 48:9, s. 1043-1048
  • Tidskriftsartikel (refereegranskat)abstract
    • To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced patients with ALS and matched controls (n = 1,861). Through imputation and mixed-model association analysis in 12,577 cases and 23,475 controls, combined with 2,579 cases and 2,767 controls in an independent replication cohort, we fine-mapped a new risk locus on chromosome 21 and identified C21orf2 as a gene associated with ALS risk. In addition, we identified MOBP and SCFD1 as new associated risk loci. We established evidence of ALS being a complex genetic trait with a polygenic architecture. Furthermore, we estimated the SNP-based heritability at 8.5%, with a distinct and important role for low-frequency variants (frequency 1-10%). This study motivates the interrogation of larger samples with full genome coverage to identify rare causal variants that underpin ALS risk.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3
Typ av publikation
tidskriftsartikel (3)
Typ av innehåll
refereegranskat (3)
Författare/redaktör
Al-Chalabi, Ammar (3)
van Damme, Philip (3)
Corcia, Philippe (3)Ta bort avgränsningen
Hardiman, Orla (3)
van den Berg, Leonar ... (3)
de Carvalho, Mamede (3)
visa fler...
Weber, Markus (3)
Grosskreutz, Julian (3)
Meyer, Thomas (3)
Andersen, Peter M. (2)
Couratier, Philippe (2)
Silani, Vincenzo (2)
Chandran, Siddhartha ... (2)
Chio, Adriano (2)
Desnuelle, Claude (2)
Ingre, Caroline (2)
Koritnik, Blaz (2)
Padovani, Alessandro (1)
Shatunov, Aleksey (1)
Jones, Ashley R. (1)
D'Alfonso, Sandra (1)
Fogh, Isabella (1)
Ticozzi, Nicola (1)
Veldink, Jan H. (1)
Pinto, Susana (1)
Povedano Panades, Mó ... (1)
Andersen, Peter M., ... (1)
Shaw, Christopher E. (1)
Shaw, Pamela J. (1)
Morrison, Karen E. (1)
Landers, John E. (1)
Glass, Jonathan D. (1)
Vourc’h, Patrick (1)
Breen, Gerome (1)
Camu, William (1)
van Rheenen, Wouter (1)
Talbot, Kevin (1)
Ratti, Antonia (1)
Danielsson, Olof (1)
Grehl, Torsten (1)
Holmoy, Trygve (1)
Karlsborg, Merete (1)
Kleveland, Grethe (1)
Christoph Koch, Jan (1)
KuzmaKozakiewicz, Ma ... (1)
Laaksovirta, Hannu (1)
Ludolph, Albert (1)
McDermott, Christoph ... (1)
Mitre Ropero, Bernar ... (1)
Mora Pardina, Jesus (1)
visa färre...
Lärosäte
Umeå universitet (3)
Karolinska Institutet (2)
Uppsala universitet (1)
Linköpings universitet (1)
Lunds universitet (1)
Språk
Engelska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy